Serratus Plain Block Versus Paravertebral Block Versus Serratus Plain Block and Paravertebral Block for Postoperative Pain Following Thoracoscopic Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

January 2, 2020

Primary Completion Date

February 22, 2023

Study Completion Date

February 22, 2023

Conditions
Anesthesia, LocalPain, Postoperative
Interventions
DRUG

loco-regional anesthesia serratus plane bloc (Ropivacaine 2 mg/mL, 40 mL) and paravertebral placebo bloc (saline, 20 mL)

Each patient who underwent thoracoscopic surgery will be assigned to one procedure of Loco-regional anesthesia

DRUG

Loco-regional anesthesia : paravertebral bloc (Ropivacaine 4 mg/mL, 20 mL) and serratus plane placebo bloc (saline, 40 mL)

Each patient who underwent thoracoscopic surgery will be assigned to one procedure of Loco-regional anesthesia.

DRUG

Loco-regional anesthesia : serratus plane bloc (Ropivacaine 1,3 mg/mL, 40 mL) and paravertebral bloc (Ropivacaine 1,3 mg/mL, 20 mL)

Each patient who underwent thoracoscopic surgery will be assigned to one procedure of Loco-regional anesthesia.

Trial Locations (1)

80054

CHU Amiens, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT04222010 - Serratus Plain Block Versus Paravertebral Block Versus Serratus Plain Block and Paravertebral Block for Postoperative Pain Following Thoracoscopic Surgery | Biotech Hunter | Biotech Hunter